For the remaining 44 patients, significant improvements were observed over the 6 months in asthma control (median (interquartile range) ACQ6 score 3.2 (2.3–4.0) to 2.5 (1.7–3.6), p<0.05), quality of life (mini-AQLQ score 3.1 (2.2–4.3) to 4.0 (3.0–5.2), p<0.05) and hospitalisations (0 (0–1) to 0 (0–0), p<0.05); with numerical improvements seen in FEV 1 (% predicted) and number of OCS bursts, but these did not reach statistical significance ( figure 1b ).
← all excerpts
Enhancing severe asthma care: real-world outcomes of a digital adherence and self-management platform.
1
—
—